CD40 stimulation and antitumor effects

Danice E C Wilkins, William J Murphy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

CD40-CD40L interactions play an important role in the generation of humoral and cell-mediated immunity. Due to the expression of CD40 on antigen presenting cells, it has become an attractive target for immunotherapy against cancer. Recent studies have focused on using CD40 stimulation as an adjuvant, and in conjunction with cytokines and other factors to elicit antitumor responses. However, due to the pleiotropic effects of CD40 stimulation, and the wide array of cell types upon which it is expressed, new studies are also focusing on the nonimmune related consequences of systemic and local CD40 stimulation. Systemic administration of immunotherapy regimens containing CD40 stimulation via soluble ligands and agonist antibodies has been associated with some toxicities, and direct stimulation of CD40 expressed on various malignancies and vascular endothelium has elucidated a possible role for CD40 in the transformation and progression of malignancies. This review focuses on the role of CD40 stimulation in the generation of innate and adaptive antitumor responses, as well as the direct effects of CD40 stimulation on tumor survival, death, and angiogenesis.

Original languageEnglish (US)
Title of host publicationTargeted Cancer Immune Therapy
PublisherSpringer New York
Pages227-239
Number of pages13
ISBN (Print)9781441901699
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

CD40 Ligand
Toxicity
Tumors
Cytokines
Ligands
Antibodies
Immunotherapy
CD40 Antigens
Neoplasms
Vascular Endothelium
Antigen-Presenting Cells
Cellular Immunity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Wilkins, D. E. C., & Murphy, W. J. (2009). CD40 stimulation and antitumor effects. In Targeted Cancer Immune Therapy (pp. 227-239). Springer New York. https://doi.org/10.1007/978-1-4419-0170-5_13

CD40 stimulation and antitumor effects. / Wilkins, Danice E C; Murphy, William J.

Targeted Cancer Immune Therapy. Springer New York, 2009. p. 227-239.

Research output: Chapter in Book/Report/Conference proceedingChapter

Wilkins, DEC & Murphy, WJ 2009, CD40 stimulation and antitumor effects. in Targeted Cancer Immune Therapy. Springer New York, pp. 227-239. https://doi.org/10.1007/978-1-4419-0170-5_13
Wilkins DEC, Murphy WJ. CD40 stimulation and antitumor effects. In Targeted Cancer Immune Therapy. Springer New York. 2009. p. 227-239 https://doi.org/10.1007/978-1-4419-0170-5_13
Wilkins, Danice E C ; Murphy, William J. / CD40 stimulation and antitumor effects. Targeted Cancer Immune Therapy. Springer New York, 2009. pp. 227-239
@inbook{8e6c1f1e59bf45c19de04012028914b8,
title = "CD40 stimulation and antitumor effects",
abstract = "CD40-CD40L interactions play an important role in the generation of humoral and cell-mediated immunity. Due to the expression of CD40 on antigen presenting cells, it has become an attractive target for immunotherapy against cancer. Recent studies have focused on using CD40 stimulation as an adjuvant, and in conjunction with cytokines and other factors to elicit antitumor responses. However, due to the pleiotropic effects of CD40 stimulation, and the wide array of cell types upon which it is expressed, new studies are also focusing on the nonimmune related consequences of systemic and local CD40 stimulation. Systemic administration of immunotherapy regimens containing CD40 stimulation via soluble ligands and agonist antibodies has been associated with some toxicities, and direct stimulation of CD40 expressed on various malignancies and vascular endothelium has elucidated a possible role for CD40 in the transformation and progression of malignancies. This review focuses on the role of CD40 stimulation in the generation of innate and adaptive antitumor responses, as well as the direct effects of CD40 stimulation on tumor survival, death, and angiogenesis.",
author = "Wilkins, {Danice E C} and Murphy, {William J}",
year = "2009",
doi = "10.1007/978-1-4419-0170-5_13",
language = "English (US)",
isbn = "9781441901699",
pages = "227--239",
booktitle = "Targeted Cancer Immune Therapy",
publisher = "Springer New York",

}

TY - CHAP

T1 - CD40 stimulation and antitumor effects

AU - Wilkins, Danice E C

AU - Murphy, William J

PY - 2009

Y1 - 2009

N2 - CD40-CD40L interactions play an important role in the generation of humoral and cell-mediated immunity. Due to the expression of CD40 on antigen presenting cells, it has become an attractive target for immunotherapy against cancer. Recent studies have focused on using CD40 stimulation as an adjuvant, and in conjunction with cytokines and other factors to elicit antitumor responses. However, due to the pleiotropic effects of CD40 stimulation, and the wide array of cell types upon which it is expressed, new studies are also focusing on the nonimmune related consequences of systemic and local CD40 stimulation. Systemic administration of immunotherapy regimens containing CD40 stimulation via soluble ligands and agonist antibodies has been associated with some toxicities, and direct stimulation of CD40 expressed on various malignancies and vascular endothelium has elucidated a possible role for CD40 in the transformation and progression of malignancies. This review focuses on the role of CD40 stimulation in the generation of innate and adaptive antitumor responses, as well as the direct effects of CD40 stimulation on tumor survival, death, and angiogenesis.

AB - CD40-CD40L interactions play an important role in the generation of humoral and cell-mediated immunity. Due to the expression of CD40 on antigen presenting cells, it has become an attractive target for immunotherapy against cancer. Recent studies have focused on using CD40 stimulation as an adjuvant, and in conjunction with cytokines and other factors to elicit antitumor responses. However, due to the pleiotropic effects of CD40 stimulation, and the wide array of cell types upon which it is expressed, new studies are also focusing on the nonimmune related consequences of systemic and local CD40 stimulation. Systemic administration of immunotherapy regimens containing CD40 stimulation via soluble ligands and agonist antibodies has been associated with some toxicities, and direct stimulation of CD40 expressed on various malignancies and vascular endothelium has elucidated a possible role for CD40 in the transformation and progression of malignancies. This review focuses on the role of CD40 stimulation in the generation of innate and adaptive antitumor responses, as well as the direct effects of CD40 stimulation on tumor survival, death, and angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84900883795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900883795&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-0170-5_13

DO - 10.1007/978-1-4419-0170-5_13

M3 - Chapter

AN - SCOPUS:84900883795

SN - 9781441901699

SP - 227

EP - 239

BT - Targeted Cancer Immune Therapy

PB - Springer New York

ER -